Meanwhile, H19 is validated to regulate EZH2 by miR-630 silencing, which is a repressor of EZH2 and interacts with H19 in a sequence-specific manner, to inhibit the expression level of E-cadherin and eventually accelerate the invasion and metastasis of NPC (58). The gene discussed is H19; the disease is nasopharyngeal carcinoma.